Literature DB >> 28381201

Etiology and pathogenesis of Moyamoya Disease: An update on disease prevalence.

Shuo Huang1, Zhen-Ni Guo1, Mingchao Shi1, Yi Yang1, Mingli Rao1.   

Abstract

Moyamoya disease is a chronic cerebrovascular occlusive disease that is characterized by progressive stenosis of the terminal portion of the internal carotid artery and its main branches. The occurrence of Moyamoya disease is related to immune, genetic, and other factors. Though the research of Moyamoya disease has made great strides in the past 60 years, the etiology and pathogenesis are largely unknown. This review will focus on the genetic pathogenic and inflammation factors of Moyamoya disease.

Entities:  

Keywords:  Moyamoya disease; epidemiology; immunology; pathogenesis

Mesh：

Year:  2017        PMID： 28381201     DOI： 10.1177/1747493017694393

Source DB:  PubMed          Journal:  Int J Stroke        ISSN： 1747-4930            Impact factor:   5.266


  17 in total

1.  Moyamoya disease and moyamoya syndrome in Ireland: patient demographics, mode of presentation and outcomes of EC-IC bypass surgery.

Authors:  Ronan J Doherty; John Caird; Darach Crimmins; Peter Kelly; Sean Murphy; Christopher McGuigan; Niall Tubridy; Mary D King; Bryan Lynch; David Webb; Desmond O'Neill; Dominick J H McCabe; Peter Boers; Mary O'Regan; Joan Moroney; David J Williams; Simon Cronin; Mohsen Javadpour
Journal:  Ir J Med Sci       Date:  2020-06-19       Impact factor: 1.568

Review 2.  Idiopathic Non-atherosclerotic Carotid Artery Disease.

Authors:  Andrea Harriott
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

3.  RNF213 gene polymorphism rs9916351 and rs8074015 significantly associated with moyamoya disease in Chinese population.

Authors:  Bin Zhu; Xingju Liu; Xueke Zhen; Xixi Li; Mingfen Wu; Yan Zhang; Zhigang Zhao; Dong Zhang; Jizong Zhao
Journal:  Ann Transl Med       Date:  2020-07

4.  Electroencephalographic features in pediatric patients with moyamoya disease in China.

Authors:  Jia Lu; Qing Xia; Tuanfeng Yang; Jun Qiang; Xianzeng Liu; Xun Ye; Rong Wang
Journal:  Chin Neurosurg J       Date:  2020-01-13

5.  Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases.

Authors:  Qinglian Li; Lai Qu; Yongjie Yuan; Baofeng Xu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-12-15

6.  Moyamoya disease presenting as thalamic infarction in a patient with neuromyelitis optica spectrum disorder.

Authors:  Yin-Xi Zhang; Yang Zheng; Meng-Ting Cai; Lei Wu; Bao-Rong Zhang
Journal:  CNS Neurosci Ther       Date:  2019-02-06       Impact factor: 5.243

7.  Mood and Stress Evaluation of Adult Patients With Moyamoya Disease in Korea: Ecological Momentary Assessment Method Using a Mobile Phone App.

Authors:  Kyu Won Shim; Mona Choi; Yong Sook Yang; Gi Wook Ryu; Chang Gi Park; Insun Yeom
Journal:  JMIR Mhealth Uhealth       Date:  2020-05-25       Impact factor: 4.773

8.  Clinical efficacy of extracranial-intracranial bypass for the treatment of adult patients with moyamoya disease: A protocol of systematic review of randomized controlled trials.

Authors:  Jun Yang; Guang-Fu Song; Hong-Bin Li; Shi-Hua Zhang; Fu-Yi Yang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

9.  Pathophysiological Significance of Neutrophilic Transfer RNA-Derived Small RNAs in Asymptomatic Moyamoya Disease.

Authors:  Lingzhi Li; Ping Liu; Rongliang Wang; Yuyou Huang; Jichang Luo; Liqun Jiao; Zhen Tao; Yangmin Zheng; Junfen Fan; Haiping Zhao; Ziping Han; Yumin Luo
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

10.  DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease.

Authors:  Adam J Kundishora; Samuel T Peters; Amélie Pinard; Daniel Duran; Shreyas Panchagnula; Tanyeri Barak; Danielle F Miyagishima; Weilai Dong; Hannah Smith; Jack Ocken; Ashley Dunbar; Carol Nelson-Williams; Shozeb Haider; Rebecca L Walker; Boyang Li; Hongyu Zhao; Dean Thumkeo; Arnaud Marlier; Phan Q Duy; Nicholas S Diab; Benjamin C Reeves; Stephanie M Robert; Nanthiya Sujijantarat; Amber N Stratman; Yi-Hsien Chen; Shujuan Zhao; Isabelle Roszko; Qiongshi Lu; Bo Zhang; Shrikant Mane; Christopher Castaldi; Francesc López-Giráldez; James R Knight; Michael J Bamshad; Deborah A Nickerson; Daniel H Geschwind; Shih-Shan Lang Chen; Phillip B Storm; Michael L Diluna; Charles C Matouk; Darren B Orbach; Seth L Alper; Edward R Smith; Richard P Lifton; Murat Gunel; Dianna M Milewicz; Sheng Chih Jin; Kristopher T Kahle
Journal:  JAMA Neurol       Date:  2021-08-01       Impact factor: 29.907
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.